2016
![](https://www.farmaindustriaticino.ch/files/2016/07/IMG_1689-160x160.jpg)
Farma Industria Ticino and Credit Suisse Award for best student
![](https://www.farmaindustriaticino.ch/files/2016/06/2-1-1024x683-160x160.jpg)
ASSEMBLEA GENERALE ORDINARIA
Helsinn Group hosts a Satellite Symposium on shared decision making in supportive care, at the Multinational Association of Supportive Care in Cancer/International Society of Oral Oncology (MASCC/ISOO) Annual Meeting 2016 on June 24th
![Helsinn Healthcare SA](http://www.farmaindustriaticino.ch/files/2015/05/logo_helsinn.png)
Helsinn Group to present at ASCO pooled follow up efficacy data analysis from two Phase III studies for anamorelin in cachectic patients with non-small cell lung cancer (NSCLC)
![Helsinn Healthcare SA](http://www.farmaindustriaticino.ch/files/2015/05/logo_helsinn.png)
Helsinn to Present at UBS Healthcare Conference in New York
![Helsinn Healthcare SA](http://www.farmaindustriaticino.ch/files/2015/05/logo_helsinn.png)
Helsinn support the Conquer Cancer Foundation/Anna Braglia Endowed Young Investigator Award in Cancer Supportive Care whit research funding support for promising young physicians
![Helsinn Healthcare SA](http://www.farmaindustriaticino.ch/files/2015/05/logo_helsinn.png)
Helsinn Healthcare SA, The University of Texas MD Anderson Cancer Center enter strategic alliance to improve life of patients conducting clinical studies in cancer supportive and palliative care
![Helsinn Healthcare SA](http://www.farmaindustriaticino.ch/files/2015/05/logo_helsinn.png)
HELSINN GROUP SIGNS EXCLUSIVE AGREEMENT WITH PURDUE PHARMA CANADA FOR THE DISTRIBUTION AND LICENSING RIGHTS OF AKYNZEO® (NETUPITANT/PALONOSETRON combo) IN CANADA
![Helsinn Healthcare SA](http://www.farmaindustriaticino.ch/files/2015/05/logo_helsinn.png)
RIVOPHARM acquires HOLSTEN Pharma
![Rivopharm SA](http://www.farmaindustriaticino.ch/files/2015/05/logo_rivopharm.png)
Linkedin